References
- SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
- LefebvreJLCurrent clinical outcomes demand new treatment options for SCCHNAnn Oncol200516Suppl 6vi7vi1215987995
- ArgirisABrocksteinBEHarafDJCompeting causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapyClin Cancer Res20041061956196215041712
- KhuriFRKimESLeeJJThe impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialCancer Epidemiol Biomarkers Prev200110882382911489748
- SanabriaACarvalhoALVartanianJGMagrinJIkedaMKKowalskiLPFactors that influence treatment decision in older patients with resectable head and neck cancerLaryngoscope2007117583584017473679
- SanabriaACarvalhoALVartanianJGMagrinJIkedaMKKowalskiLPComorbidity is a prognostic factor in elderly patients with head and neck cancerAnn Surg Oncol20071441449145717235712
- HopkinsJCesconDWTseDGenetic polymorphisms and head and neck cancer outcomes: a reviewCancer Epidemiol Biomarkers Prev200817349049918349267
- PearsonWRVorachekWRXuSJIdentification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13Am J Hum Genet19935312202338317488
- XuSWangYRoeBPearsonWRCharacterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletionJ Biol Chem19982736351735279452477
- RoweJDNievesEListowskyISubunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antiseraBiochem J1997325Pt 24814869230131
- GeislerSAOlshanAFGSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE reviewAm J Epidemiol200115429510511447041
- SongDKXingDLZhangLRLiZXLiuJQiaoBPAssociation of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central ChinaCancer Detect Prev2009325–641642319303722
- GolkaKHermesMSelinskiSSusceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposurePharmacogenet Genomics2009191190390619801959
- OlivieriEHda SilvaSDMendonçaFFCYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patientsOral Oncol2009459e73e7919442564
- SyamalaVSSreejaLSyamalaVInfluence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survivalFam Cancer20087321322018080216
- PandeySNJainMNigamPChoudhuriGMittalBGenetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North IndiaBiomarkers200611325026116760134
- SharmaAMishraADasBCSardanaSSharmaJKGenetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancerNeoplasma200653430931516830058
- KingRSTeitelCHKadlubarFFIn vitro bioactivation of N-hydroxy-2-amino-alpha-carbolineCarcinogenesis20002171347135410874013
- ColesBFKadlubarFFDetoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?Biofactors2003171–411513012897434
- HildebrandtMALippmanSMEtzelCJGenetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemopreventionClin Cancer Res201218133705371322577058
- WangJLippmanSMLeeJJGenetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaCarcinogenesis201031101755176120627871
- WuXSpitzMRLeeJJNovel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsCancer Prev Res (Phila)20092761762419584075
- ZhangXYangHLeeJJMicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerCarcinogenesis201031122118212320819778
- KhuriFRLippmanSMSpitzMRLotanRHongWKMolecular epidemiology and retinoid chemoprevention of head and neck cancerJ Natl Cancer Inst19978931992119017000
- DikshitRPBoffettaPBouchardyCRisk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinomaCancer2005103112326233315852357
- RussoACrosignaniPBerrinoFTobacco smoking, alcohol drinking and dietary factors as determinants of new primaries among male laryngeal cancer patients: a case-cohort studyTumori19968265195259061057
- VineisPPirastuRAromatic amines and cancerCancer Causes Control1997833463559498898
- HashibeMBrennanPStrangeRCMeta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancerCancer Epidemiol Biomarkers Prev200312121509151714693745
- ChengLSturgisEMEicherSACharDSpitzMRWeiQGlutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neckInt J Cancer199984322022410371337
- MinardCGSpitzMRWuXHongWKEtzelCJEvaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancerCancer2006106122636264416703596
- SinghMShahPPSinghAPAssociation of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancerMutat Res20086381–218419418035380
- MatthiasCHarréusUStrangeRInfluential factors on tumor recurrence in head and neck cancer patientsEur Arch Otorhinolaryngol20062631374216003553
- ZafereoMESturgisEMAleemSChaungKWeiQLiGGlutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neckCancer Prev Res (Phila Pa)200925432439
- GeislerSAOlshanAFCaiJWeisslerMSmithJBellDGlutathione S-transferase polymorphisms and survival from head and neck cancerHead Neck200527323224215668931
- WorrallSFCorriganMHighASusceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6Pharmacogenetics1998854334399825835
- NørskovMSFrikke-SchmidtRBojesenSENordestgaardBGLoftSTybjærg-HansenACopy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general populationPharmacogenomics J201111429229920514077
- McLellanRAOscarsonMAlexandrieAKCharacterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activityMol Pharmacol19975269589659415705
- BartleyPAKeoughRALutwycheJKGondaTJRegulation of the gene encoding glutathione S-transferase M1 (GSTM1) by the Myb oncoproteinOncogene200322487570757514576818
- YuKDDiGHFanLA functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancerFASEB J20092372274228719228880